Sintilimab Plus Bevacizumab as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Curative Resection
Clinical trial NCT04682210 · UNKNOWN
Trial details
- NCT number
- NCT04682210
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2023-12-01
- Enrollment
- 246
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.